Provided by Tiger Trade Technology Pte. Ltd.

Aura Biosciences, Inc.

7.50
+0.07000.94%
Post-market: 7.500.00000.00%16:15 EDT
Volume:495.49K
Turnover:3.70M
Market Cap:775.40M
PE:-4.23
High:7.67
Open:7.46
Low:7.00
Close:7.43
52wk High:9.54
52wk Low:4.73
Shares:103.39M
Float Shares:79.92M
Volume Ratio:0.96
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7726
EPS(LYR):-1.7599
ROE:-53.49%
ROA:-31.24%
PB:2.46
PE(LYR):-4.26

Loading ...

Major Investor Makes Dramatic Exit from Aura Biosciences

TIPRANKS
·
May 12

Aura Biosciences Q1 EPS $(0.50) Misses $(0.39) Estimate

Benzinga Earnings
·
May 12

Aura Biosciences reports Q1 results, appoints new CEO

TIPRANKS
·
May 12

Aura Biosciences posts corporate presentation on global oncology pipeline, lead EGFR TKI firmonertinib

Reuters
·
May 12

Matrix Capital Management reports disposal of 6,922,870 Aura Biosciences shares for $39.05 million

Reuters
·
May 12

Aura Biosciences Q1 net loss widens to $33.7 million

Reuters
·
May 12

BRIEF-Aura Biosciences Q1 Operating Expenses USD 34.866 Million

Reuters
·
May 12

Press Release: Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights

Dow Jones
·
May 12

Aura Biosciences CEO Natalie Holles files initial beneficial ownership statement

Reuters
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Aura Biosciences Completes Major Underwritten Equity Financing

TIPRANKS
·
May 06

Press Release: Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
May 06

Aura Biosciences Announces Stock Repurchase Agreement with Shareholder

TIPRANKS
·
May 05

Aura Biosciences repurchases Matrix stake for USD 39.04 million at USD 5.64/share

Reuters
·
May 05

Aura Biosciences $260M Spot Secondary priced at $6.00

TIPRANKS
·
May 04

Aura Biosciences Inc - Offering Price Set at $6.00 per Share and $5.99999 per Pre-Funded Warrant

THOMSON REUTERS
·
May 04

Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
May 04

Aura Biosciences launches underwritten public stock offering with pre-funded warrants

Reuters
·
May 04

Aura Biosciences names Natalie Holles CEO, replacing founder Elisabet de los Pinos

Reuters
·
May 04

Aura Biosciences Inc - Expects Phase 3 Compass Trial Enrollment Completion by Mid-2026 and Topline Data in Second Half of 2027

THOMSON REUTERS
·
May 04